An Emergency Medicine Broadsheet
·Phoenix·
Est. MMXXVI
Blue Fish Med · Today's Topic
Minor Procedures and Sedation/Analgesia
Procedural sedation can convert a frightened, struggling child into a cooperative patient—or into an apneic one. Safe sedation is less about choosing a favorite drug than anticipating depth, airway risk, and rescue needs.
A 7-year-old boy sits rigidly on the stretcher, tears tracking through the dirt on his cheeks as he grips a bloodied forearm. A deep, gaping laceration crosses the volar wrist, and every attempt to examine it produces a sharp cry and a retreating elbow. His mother asks whether he will remember what happens next. The wound is waiting, but the room has not yet decided how to make its repair safe and tolerable.
— What’s your move? Read on.
Before you read
What must be checked before sedating a child?
Which rescue actions matter when ventilation deteriorates?
When to Think of It
Use a sedation/analgesia plan for painful procedures, immobility, severe anxiety, or inability to cooperate despite preparation and local anesthesia. First decide whether the goal is anxiolysis, moderate sedation, dissociation, or general anesthesia; deeper-than-intended sedation is always possible.
Sick or Not Sick
Sick vs. not sick: Can this patient maintain oxygenation and ventilation if sedation becomes deeper than planned? Identify airway abnormalities, respiratory disease, hemodynamic instability, aspiration risk, altered mental status, difficult IV access, and ASA class III–IV. The key call is whether the ED team and setting can rescue the likely depth of sedation.
The First Fifteen Minutes
Before medication: focused airway/medical assessment, weight, allergies, last oral intake, baseline vitals, consent, IV/IM/IN access as appropriate; continuous pulse oximetry, cardiac monitoring, frequent respiratory assessment, and capnography when available. Have suction, oxygen, bag-mask ventilation, airway equipment, and a dedicated monitor ready.
If pain is significant before sedation → fentanyl 1–2 mcg/kg IV, or 1.5–2 mcg/kg intranasal if no IV (usual maximum 100 mcg; check institutional pediatric protocol), because μ-opioid analgesia reduces procedural pain but can depress ventilation.
If mild-to-moderate anxiety with preserved cooperation → midazolam 0.05–0.1 mg/kg IV (maximum 5 mg) or 0.2–0.3 mg/kg intranasal (maximum 10 mg; check reference), because rapid GABA-A anxiolysis reduces distress; it provides unreliable analgesia.
If dissociative analgesia and immobility are needed → ketamine 1–2 mg/kg IV over 1–2 minutes, with 0.5–1 mg/kg IV supplemental doses as needed; if no IV, 4 mg/kg IM, with 2 mg/kg IM repeat dosing if necessary. Ketamine preserves airway reflexes and provides analgesia, though laryngospasm and vomiting can occur.
If using nitrous oxide for brief, minimally invasive procedures → 50% nitrous oxide/50% oxygen by inhalation, titrated upward or downward per equipment and protocol, because anxiolysis and analgesia occur rapidly and wear off quickly; avoid with pneumothorax, bowel obstruction, significant altered mental status, or inability to cooperate.
If opioid or benzodiazepine respiratory depression occurs → support airway and ventilation first; naloxone 0.1 mg/kg IV/IM/IN (maximum 2 mg per dose) for clinically significant opioid-induced respiratory depression, because it competitively reverses μ-opioid effects. Flumazenil 0.01 mg/kg IV (maximum 0.2 mg per dose; maximum cumulative 1 mg) may reverse isolated benzodiazepine effect, but avoid in chronic benzodiazepine use, seizure disorders, or mixed/unknown overdose; consult a toxicology reference.
If vomiting occurs during ketamine sedation → lateral positioning, suction, oxygen, and airway support; routine prophylaxis is not required. If severe agitation or emergence reaction threatens safety → reassess oxygenation, glucose, and depth before considering additional medication.
Definitive Care & Disposition
Provide local anesthetic whenever feasible; procedural sedation does not replace wound anesthesia. Complete the procedure, reassess pain and mental status, and document drug, dose, times, depth, monitoring, adverse events, and discharge criteria. Discharge only when the child returns to baseline mentation, has stable vital signs, a patent airway, adequate hydration, controlled pain, and responsible supervision; give no driving, climbing, swimming, or hazardous activity for the remainder of the day. Admit or obtain anesthesia consultation for persistent respiratory compromise, serious adverse events, unstable comorbidity, or inability to return to baseline.
How This One Kills
The dangerous miss is treating sedation as medication administration rather than airway management: a child receives repeated opioid/benzodiazepine doses without capnography or a dedicated observer, hypoventilates, and progresses to hypoxic arrest before anyone recognizes the change.
The Differential — What Else Looks Like This
Uncontrolled pain despite “sedation” — tachycardia and movement improve with local anesthetic, not escalating sedative; confusing the two causes respiratory depression.
Hypoglycemia or hypoxia — altered behavior may precede obvious vital-sign changes; attributing it to anxiety delays correction.
Intracranial injury or intoxication — abnormal mental status is not a routine sedation target; sedating before evaluation can obscure deterioration.
Local anesthetic systemic toxicity — perioral numbness, tinnitus, seizures, or dysrhythmia after infiltration; confusing it with agitation leads to more anesthetic.
The Second-Day Story
The high-risk child may look deceptively calm: an infant is quiet rather than cooperative, an exhausted child has already lost compensatory reserve, or a child with autism cannot communicate pain or impending airway trouble. Conversely, paradoxical agitation after midazolam may be mistaken for inadequate dosing. Use objective respiratory monitoring, observe chest movement and airway tone, and titrate to the intended endpoint rather than behavior alone.
Back to Our Patient
Back to the 7-year-old with the bloodied volar-wrist laceration: he is alert, hemodynamically stable, has no airway abnormality or respiratory disease, and can answer questions but cannot tolerate wound exploration. Recognize this as a painful procedure requiring immobility; risk stratify him as an appropriate ED sedation candidate after focused airway assessment and consent. The team places monitoring and capnography, prepares suction and bag-mask equipment, gives weight-based analgesia and ketamine dissociation, infiltrates local anesthetic, irrigates and repairs the wound, and watches until he returns to baseline. He is discharged with his mother after stable ambulation, oral intake, wound-care instructions, and activity restrictions.
Patient Presentation to Attending
How you’d present this patient on the floor — tight, pertinent positives and negatives, no rambling
“This is a previously healthy 7-year-old boy with a deep volar-wrist laceration sustained on broken glass shortly before arrival, with severe pain and inability to tolerate examination or repair. He is alert, protecting his airway, breathing comfortably, and has no vomiting, head injury, intoxication, or significant medical history. The wound is gaping but bleeding is controlled, distal perfusion and sensation are intact, and there is no obvious tendon deficit on limited examination. He is hemodynamically stable and appropriate for ED procedural sedation after consent and airway assessment. My plan is monitored ketamine sedation with local anesthetic, irrigation and exploration for tendon or foreign-body injury, repair, tetanus assessment, and observation to baseline before discharge.”
Study Directive
Draw a pre-sedation checklist from memory: indication, depth, airway, fasting, consent, monitoring, rescue equipment, and recovery.
Calculate fentanyl, ketamine, and naloxone doses for a 12-, 25-, and 40-kg child.
Practice a 60-second airway rescue sequence for sedation-related apnea.
Review your institutional procedural-sedation policy and compare it with Lexicomp or UpToDate.
Observe or perform one sedation and document intended depth, actual depth, adverse events, and recovery criteria.
Children can compensate for respiratory disease until fatigue, hypoxemia, and dehydration arrive together. The ED priority is not proving an infiltrate; it...
Also known asCAP · community-acquired pneumonia · pneumonitis · lobar pneumonia
A 3-year-old girl leans against her father, cheeks flushed and curls damp with sweat. Her breaths are fast enough to lift the hem of her pajama shirt, and a faint grunt appears each time she exhales. She has taken only a few sips since yesterday and keeps pointing to her chest when she coughs. The monitor is showing a number, but the more urgent question is whether she can keep breathing this way.
Before You Read
Which findings make pediatric pneumonia dangerous rather than merely radiographic?
When are antibiotics indicated, and which child needs admission?
What diagnosis must be considered when wheeze dominates?
Why It Matters
Children can compensate for respiratory disease until fatigue, hypoxemia, and dehydration arrive together. The ED priority is not proving an infiltrate; it is recognizing respiratory failure, identifying likely pathogens, and delivering timely supportive care and antibiotics when bacterial disease is plausible.
When to Think of It
Fever, cough, tachypnea, increased work of breathing, hypoxemia, pleuritic discomfort, focal crackles or decreased breath sounds, or toxic appearance should raise concern. Pneumonia can occur without fever, and auscultation may be normal early or difficult in a distressed child. Routine chest radiography is not required for uncomplicated outpatient disease; obtain it for severe illness, hypoxemia, diagnostic uncertainty, complications, or failure to improve.
Sick or Not Sick
Sick vs. not sick: Can the child maintain oxygenation and ventilation without unsustainable work of breathing? Admission is favored by hypoxemia, apnea, grunting, marked retractions, exhaustion, altered mental status, dehydration, sepsis, significant comorbidity, multilobar disease, effusion, or unreliable follow-up.
The First Fifteen Minutes
Place on pulse oximetry, assess work of breathing and perfusion, obtain IV/IO access if ill, and check glucose when altered or profoundly ill.
If hypoxemic → oxygen by nasal cannula 1–4 L/min in a young child, titrated to keep saturation generally ≥90% (institutional targets may differ), because increased inspired oxygen corrects diffusion/V-Q impairment.
If moderate-to-severe distress or persistent hypoxemia despite standard oxygen → high-flow nasal cannula, commonly 2 L/kg/min for infants/young children, up to 50–60 L/min, titrated per local protocol, because heated flow reduces inspiratory demand and work of breathing. Flow limits and escalation vary; check institutional guidance.
If shock or significant dehydration with poor perfusion → isotonic crystalloid 10–20 mL/kg IV/IO, reassessing after each bolus for pulmonary edema, because restoring preload improves tissue perfusion; use smaller aliquots in myocardial dysfunction or severe respiratory failure.
If bacterial pneumonia is suspected and the child is toxic, hypoxemic, or being admitted → ceftriaxone 50–75 mg/kg IV/IM (maximum 2 g), because it provides empiric coverage for common invasive bacterial pathogens. If severe pneumococcal disease or local resistance concerns → add vancomycin 15 mg/kg IV (dose/interval should be pharmacy- or protocol-guided) for resistant pneumococcus/MRSA coverage.
If uncomplicated, immunized, stable outpatient bacterial pneumonia is likely → amoxicillin 90 mg/kg/day PO divided twice daily (maximum commonly 4 g/day; verify local protocol), because high-dose therapy targets pneumococcus.
If influenza is suspected and illness is severe, hospitalized, or within the treatment window → oseltamivir 3 mg/kg PO twice daily for 5 days in children ≥1 year; dosing differs by age/weight and should be checked in a current reference, because neuraminidase inhibition reduces viral replication.
If bronchospasm accompanies pneumonia → albuterol 2.5 mg nebulized (or 4–8 puffs by MDI with spacer), because β2-mediated bronchodilation treats reversible airflow obstruction; wheeze alone should not trigger antibiotics.
Definitive Care & Disposition
Admit children requiring oxygen, HFNC, IV fluids, parenteral antibiotics, close respiratory observation, or treatment of complications. Seek ultrasound or radiography for suspected effusion; drain a large, loculated, or clinically significant parapneumonic effusion and involve surgery/infectious disease when needed. Transition to oral therapy when improving and tolerating intake; uncomplicated bacterial pneumonia commonly receives about 5 days of therapy, while complicated disease requires longer, guided by local recommendations and response.
How This One Kills
The key failure is anchoring on the oxygen saturation while ignoring fatigue: a child with falling respiratory effort, altered interaction, and rising CO₂ may appear “less distressed” immediately before apnea and arrest.
The Atypical Presentation
Infants may present with poor feeding, apnea, hypothermia, irritability, or isolated tachypnea rather than cough and fever. Older children can have headache, abdominal pain, or vomiting, especially with lower-lobe disease. Partially treated pneumonia may have little fever or auscultatory asymmetry; trend respiratory rate, hydration, oxygen requirement, and behavior rather than relying on a single examination.
Back to Our Patient
Back to the 3-year-old with sweaty curls and grunting: she has tachypnea, retractions, poor intake, and hypoxemia, making pneumonia with clinically significant respiratory distress likely and placing her in the sick branch. She receives monitoring, supplemental oxygen, cautious isotonic fluid after perfusion assessment, and IV ceftriaxone because of toxic appearance and need for admission; bedside lung ultrasound or radiography evaluates consolidation and effusion. Her work of breathing persists, so the team escalates respiratory support and admits her to a monitored pediatric bed/PICU depending on response, rather than waiting for a radiographic label.
Patient Presentation to Attending
“This is a previously healthy 3-year-old girl with 2 days of fever and cough, now with worsening tachypnea, poor oral intake, and decreased activity. She has no choking episode, stridor, urticaria, or known cardiac disease. She is febrile, tachycardic, hypoxemic on room air, and has grunting, subcostal retractions, and focal crackles with decreased breath sounds at the right base. Perfusion is borderline but she has no altered mental status or apnea. I’m concerned for bacterial right lower-lobe pneumonia with respiratory distress and dehydration; I’ll provide oxygen, obtain IV access, give cautious fluids and ceftriaxone, assess for effusion, and admit for respiratory monitoring with escalation to HFNC if needed.”
Study Directive
Memorize age-based tachypnea thresholds and practice identifying retractions, grunting, head bobbing, and fatigue in three videos or bedside cases.
Calculate amoxicillin, ceftriaxone, and vancomycin doses for a 10-, 20-, and 30-kg child.
Review your local pathway for outpatient, ward, and PICU pneumonia criteria.
Perform or review one pediatric lung ultrasound for consolidation and pleural effusion.
Write a one-minute escalation plan from nasal cannula to HFNC to intubation.
Key Medications
Amoxicillin: 90 mg/kg/day PO divided twice daily; verify maximum and local duration.
Ceftriaxone: 50–75 mg/kg IV/IM daily, maximum 2 g.
Cefotaxime, where preferred: 50 mg/kg IV every 6 hours; verify institutional maximum and interval.
Vancomycin: 15 mg/kg IV per dose; interval and trough/AUC monitoring vary—check pharmacy protocol.
Azithromycin when atypical pneumonia is strongly suspected: 10 mg/kg PO/IV day 1, then 5 mg/kg daily days 2–5; routine empiric use in preschool children is not recommended.
Oseltamivir: age- and weight-based; commonly 3 mg/kg PO twice daily for children ≥1 year, but verify current CDC/institutional dosing.
Albuterol: 2.5 mg nebulized or 4–8 MDI puffs with spacer.
Antibiotic duration and escalation vary with age, vaccination status, local resistance, and complications; check institutional guidance. Pediatric doses must be weight-based.
High-Yield Pearls
In a child with pneumonia, work of breathing and oxygen requirement—not fever height or radiograph size—drive disposition.
Sudden onset with unilateral findings should keep foreign-body aspiration high even when a fever develops later.
A falling respiratory rate in an exhausted child may signal impending failure, not improvement.
The Mimics
Asthma or viral bronchiolitis — diffuse wheeze and prolonged expiration without focal findings; unnecessary antibiotics delay bronchodilator/respiratory support.
Foreign-body aspiration — abrupt onset, unilateral wheeze or decreased breath sounds, often without fever; antibiotics do not remove the obstruction.
Croup or upper-airway disease — stridor rather than crackles; treating as lower respiratory infection misses airway edema.
Heart failure — hepatomegaly, gallop, poor weight gain, or cardiomegaly; repeated fluid boluses worsen pulmonary edema.
Board Question
A previously healthy, fully immunized 4-year-old has fever, cough, tachypnea, focal crackles, normal oxygen saturation, no retractions, and is drinking well. Which is the most appropriate management?
ARoutine chest radiograph and IV ceftriaxone
BOral high-dose amoxicillin as an outpatient
CVancomycin plus ceftriaxone and PICU admission
DNo treatment because most pediatric pneumonia is viral
Reveal answer
Correct: B
Oral high-dose amoxicillin as an outpatient. A stable child with a compatible focal bacterial presentation can be treated empirically with oral high-dose amoxicillin without routine imaging. The absence of hypoxemia or significant work of breathing supports outpatient care.
A current emergency medicine–focused reference for diagnosing pediatric community-acquired pneumonia, choosing empiric antibiotics, assessing severity, and determining disposition.
3 of 6
Varicella
Varicella is usually self-limited but can cause pneumonia, cerebellitis, bacterial superinfection, and severe disseminated disease in vulnerable hosts. The...
Also known aschickenpox · VZV · varicella zoster
0:00 / –:––AI‑generated audio
The Case
A 6-year-old girl arrives with her mother, who keeps her wrapped in a fleece blanket despite the August heat. New itchy spots dot the child’s scalp, face, and trunk; some are tiny clear bubbles, others are crusted, and she scratches until thin red lines appear. She has been febrile and tired but is still drinking. In the waiting room, a pregnant woman sits three chairs away, and the next move has not yet been made.
Before You Read
Which rash pattern distinguishes varicella from other vesicular illnesses?
Who needs antiviral therapy or post-exposure prophylaxis?
What must the ED do immediately to prevent transmission?
Why It Matters
Varicella is usually self-limited but can cause pneumonia, cerebellitis, bacterial superinfection, and severe disseminated disease in vulnerable hosts. The ED must recognize the rash, isolate promptly, and identify contacts or patients at high risk.
When to Think of It
Pruritic vesicles appearing in crops, with lesions in different stages—macules, papules, clear vesicles, pustules, and crusts—beginning on the trunk/face and spreading, are classic. Fever and malaise often precede or accompany the rash. Breakthrough infection after vaccination may be milder and more maculopapular, with fewer lesions and less fever.
Sick or Not Sick
Sick vs. not sick: Is this uncomplicated varicella in an immunocompetent child, or disseminated/complicated infection in a high-risk host? Red flags include respiratory distress, pneumonia, encephalitis, ataxia, severe dehydration, hemorrhagic lesions, extensive disease, pregnancy, immunocompromise, neonate exposure, and severe bacterial superinfection.
The First Fifteen Minutes
Immediately place the patient in airborne and contact precautions, ideally an airborne infection isolation room; varicella spreads by aerosol and direct contact.
If hypoxemic or in respiratory distress → oxygen by nasal cannula 1–4 L/min, titrated to adequate saturation, because oxygen corrects hypoxemia from pneumonitis.
If bacterial superinfection is suspected—rapidly expanding erythema, pain, purulence, fever out of proportion → cefazolin 25 mg/kg IV every 8 hours (maximum 2 g/dose; check local protocol), because it covers common streptococcal and MSSA skin pathogens. Add MRSA-active therapy according to local epidemiology and severity.
If severe, disseminated, or immunocompromised disease → acyclovir 10 mg/kg IV every 8 hours (maximum and renal adjustment require protocol/reference), because inhibition of viral DNA polymerase limits replication; start early and involve infectious disease.
If an immunocompetent child presents within 24 hours of rash onset with substantial disease or risk factors where treatment is favored → acyclovir 20 mg/kg PO four times daily (maximum 800 mg/dose) for 5 days, checking current pediatric guidance because routine use in otherwise healthy children is not universal.
For itch → cetirizine 0.25 mg/kg PO daily (maximum 10 mg/day), because H1 blockade reduces pruritus; avoid aspirin because of Reye syndrome risk. Use acetaminophen 15 mg/kg PO every 4–6 hours (maximum 75 mg/kg/day) for fever; avoid ibuprofen when possible because of reported association with severe invasive skin infection in varicella.
If a recently exposed high-risk patient is identified → arrange varicella-zoster immune globulin 125 IU/10 kg IM, maximum 625 IU, ideally within 96 hours and potentially up to 10 days per public-health guidance; dose and availability require current protocol.
Definitive Care & Disposition
Uncomplicated immunocompetent children can usually go home with isolation instructions, hydration, skin care, warning signs, and public-health notification per jurisdiction. Keep away from school and susceptible contacts until all lesions crust, typically about 5–7 days after onset. Admit patients with pneumonia, encephalitis, severe dehydration, extensive disease, immunocompromise, pregnancy-related concern, or inability to isolate safely. Vaccination after exposure is appropriate for susceptible immunocompetent contacts within 3–5 days, coordinated with public health.
How This One Kills
The dangerous miss is sending a contagious child through a crowded waiting room—or missing an immunocompromised contact—allowing transmission to a pregnant person, neonate, or severely immunocompromised patient.
The Atypical Presentation
Vaccinated children may have a few nonvesicular papules, little fever, and no clear “crops,” while adults, pregnant patients, and immunocompromised people may develop severe pneumonitis, hemorrhagic lesions, or disseminated disease. Ask about vaccination, immune status, pregnancy exposure, and lesion timing; PCR from a vesicle or scab is the preferred confirmatory test when the diagnosis is uncertain.
Back to Our Patient
Back to the 6-year-old with lesions in multiple stages: the pruritic crops beginning on the scalp and trunk, with vesicles and crusts simultaneously present, identify varicella. She is drinking, oxygenating normally, and has no neurologic or respiratory red flags, so she belongs in the uncomplicated branch. The team places her in airborne/contact isolation, provides symptomatic care and strict return precautions, confirms vaccination and household risk, and coordinates public-health guidance; she is discharged with instructions to avoid susceptible contacts until all lesions crust.
Patient Presentation to Attending
“This is a previously healthy 6-year-old girl with 2 days of fever and a progressively pruritic vesicular rash that began on the scalp and trunk and is now present on the face and extremities. Lesions are in different stages, including papules, clear vesicles, and crusts, with no mucosal involvement, respiratory distress, ataxia, or altered mental status. She is drinking and has normal oxygenation and perfusion. The pattern is most consistent with uncomplicated varicella. I’ve initiated airborne and contact precautions, will provide acetaminophen and cetirizine, assess household pregnancy or immunocompromise, and discharge with isolation, hygiene, and return precautions if she remains stable.”
Study Directive
Sketch varicella, zoster, hand-foot-mouth disease, and smallpox lesion distributions from memory.
Memorize the isolation window and indications/timing for varicella vaccine and VZIG.
Calculate oral and IV acyclovir doses for a 20-kg child and identify renal-adjustment issues.
Review your local public-health reporting and exposure-management pathway.
Practice a discharge script that protects pregnant, neonatal, and immunocompromised contacts.
Key Medications
Acyclovir PO: 20 mg/kg/dose four times daily, maximum 800 mg/dose for 5 days in selected children; verify whether treatment is indicated.
Acyclovir IV: 10 mg/kg every 8 hours for severe disease; renal adjustment and obesity dosing require institutional/pharmacy guidance.
Cetirizine: 0.25 mg/kg PO daily, maximum 10 mg/day.
Acetaminophen: 15 mg/kg PO every 4–6 hours, maximum 75 mg/kg/day; avoid aspirin.
Cefazolin: 25 mg/kg IV every 8 hours, maximum 2 g/dose; adjust to local protocol and renal function.
VZIG: 125 IU/10 kg IM, maximum 625 IU; current public-health guidance should be checked.
Pediatric dosing varies by age, weight, renal function, and immune status; verify uncertain doses in Lexicomp, UpToDate, or institutional protocols.
High-Yield Pearls
Varicella is contagious from about 48 hours before rash onset until every lesion has crusted.
Avoid ibuprofen when alternatives are available; invasive group A streptococcal skin infection is the feared complication.
A few atypical papules in a vaccinated child do not exclude varicella—use exposure history and PCR when needed.
The Mimics
Disseminated zoster — dermatomal pain or a localized unilateral distribution precedes dissemination; confusion delays antiviral treatment and infection control.
Impetigo — honey-colored crust without successive crops of vesicles; confusing it leads to inappropriate antiviral management.
Smallpox — lesions are more synchronous and deep, with prominent toxicity; failure to recognize it is a public-health emergency.
Board Question
Which finding is most characteristic of primary varicella infection?
AVesicles confined to one unilateral dermatome
BLesions all at the same stage of development
CPruritic lesions in crops at multiple stages
DPainful oral ulcers with lesions limited to palms and soles
Reveal answer
Correct: C
Pruritic lesions in crops at multiple stages. Varicella produces successive crops of lesions, so macules, papules, vesicles, pustules, and crusts may coexist. A unilateral dermatome suggests zoster; acral lesions with oral ulcers suggest hand-foot-mouth disease.
Provides a broad clinical framework for recognizing primary varicella, identifying patients at risk for severe complications, and distinguishing it from herpes zoster in the emergency setting.
Measles is extraordinarily contagious, and a missed diagnosis can expose an entire ED, school, or household. The initial response—airborne isolation,...
Also known asviral exanthem · febrile rash · exanthems
A 19-year-old college student sits apart from the other patients, eyes red and watery beneath a surgical mask. Four days of fever and cough have left him hoarse; now a dusky rash has begun along his hairline and behind his ears, while his roommate scrolls anxiously through photos of the dorm. He says he never saw a doctor because he thought it was “just a bad flu.” The waiting room has already become part of the investigation.
Before You Read
Which clinical sequence makes measles more likely than other exanthems?
What isolation and post-exposure steps cannot wait for test confirmation?
How do rubella, roseola, mumps, and CMV separate from measles?
Why It Matters
Measles is extraordinarily contagious, and a missed diagnosis can expose an entire ED, school, or household. The initial response—airborne isolation, public-health notification, specimen collection, and contact protection—matters before the laboratory result returns.
When to Think of It
Think measles with high fever followed by the “3 Cs”: cough, coryza, and conjunctivitis, plus Koplik spots and a maculopapular rash beginning at the hairline/face and spreading downward. Ask about MMR vaccination, travel, outbreak exposure, and immunocompromise. Consider the “friends” when the rash or systemic pattern does not fit.
Sick or Not Sick
Sick vs. not sick: Is there hypoxemic pneumonia, encephalitis, severe dehydration, or an immunocompromised/pregnant/high-risk host? The management fork is not merely “measles or not”; it is contagious patient versus critically ill patient requiring respiratory, neurologic, and public-health escalation.
The First Fifteen Minutes
Immediately place the patient in an airborne infection isolation room; staff should use a fit-tested N95 or equivalent. Mask the patient during transport and notify infection prevention/public health, because transmission can occur before confirmation.
If hypoxemic → oxygen by nasal cannula 1–4 L/min, titrated to adequate saturation, because supplemental oxygen corrects hypoxemia from viral pneumonitis or bacterial superinfection.
If dehydration or shock is present → isotonic crystalloid 10–20 mL/kg IV/IO, reassessing perfusion and lungs, because restoring intravascular volume improves tissue delivery; adults generally receive 500–1000 mL IV bolus, adjusted for cardiac/renal disease.
If measles is suspected → vitamin A 200,000 IU PO once daily for 2 days in adults and children ≥12 months; age-based pediatric doses are 100,000 IU daily for 6–11 months and 50,000 IU daily for <6 months. Vitamin A reduces complications in deficient or severe cases; coordinate with public health because dosing and toxicity matter.
If bacterial pneumonia or sepsis is suspected → ceftriaxone 1–2 g IV daily in adults or 50–75 mg/kg IV in children, because measles damages respiratory epithelium and predisposes to bacterial infection. Add vancomycin 15–20 mg/kg IV when MRSA or resistant pneumococcal disease is a concern; dosing requires pharmacy/protocol guidance.
If influenza is a competing or coexisting diagnosis and illness is severe/hospitalized → oseltamivir 75 mg PO twice daily for adults; pediatric dosing is age/weight based and should be checked, because early antiviral therapy may reduce influenza complications.
Do not administer empiric antibiotics or steroids solely for a rash. If encephalitis, airway compromise, or severe pneumonitis develops, manage in a resuscitation setting and consult critical care/infectious disease.
Definitive Care & Disposition
Collect nasopharyngeal/throat swab and urine for measles RT-PCR and serum measles IgM according to public-health instructions; do not delay isolation or notification. Uncomplicated patients require public-health-directed follow-up and strict isolation through 4 days after rash onset; admit those with hypoxemia, pneumonia, encephalitis, severe dehydration, immunocompromise, pregnancy-related concerns, or inability to isolate. Susceptible exposed contacts may receive MMR within 72 hours of first exposure or immunoglobulin within 6 days, with product and dosing selected by public health. Evaluate close contacts for rubella risk in pregnancy.
How This One Kills
The classic failure is allowing a febrile coughing patient with conjunctivitis to sit unmasked in triage while waiting for a rash diagnosis; measles transmission in the ED can continue through the air after the patient leaves.
The Atypical Presentation
In vaccinated people, older adults, or partially immune patients, fever and rash may be muted, Koplik spots absent, and the rash incomplete. Infants may have nonspecific fever, poor feeding, or pneumonia; immunocompromised patients may have severe disease without a typical rash. A careful vaccination/travel/exposure history, conjunctivitis, cough-coryza sequence, and immediate isolation are more reliable than waiting for a textbook eruption.
Back to Our Patient
Back to the 19-year-old with red eyes and a rash beginning behind the ears: the fever followed by cough, coryza, conjunctivitis, and cephalocaudal rash makes measles the leading diagnosis. He is currently oxygenating and perfusing normally, so he is not in the critically ill branch, but he is an urgent infection-control and public-health case. The team isolates him in an airborne room, uses N95 protection, collects PCR/serology specimens, provides supportive care and vitamin A after consultation, identifies and reports exposed contacts, and discharges or admits according to hydration, respiratory status, and ability to isolate—never returning him to the general waiting room.
Patient Presentation to Attending
“This is a 19-year-old college student with 4 days of fever, cough, rhinorrhea, and bilateral conjunctivitis, followed today by a maculopapular rash beginning at the hairline and behind the ears. He reports incomplete vaccination history and a recent roommate who returned from international travel; he has no new medication exposure, focal bacterial source, dyspnea, or altered mental status. He is febrile but hemodynamically stable and maintaining oxygenation. The presentation is highly concerning for measles. He is already in airborne isolation; I’ll notify infection prevention and public health, obtain measles PCR and IgM per protocol, assess and protect contacts, provide supportive care and vitamin A in consultation, and determine disposition based on hydration, respiratory status, and isolation capability.”
Study Directive
Create a four-column differential for measles, rubella, roseola, and parvovirus: prodrome, rash sequence, nodes, and complications.
Memorize measles isolation timing, specimen types, and post-exposure windows for MMR and immune globulin.
Practice the first telephone report to infection prevention/public health using a simulated case.
Review your hospital’s airborne isolation and measles testing protocol.
Draw the measles transmission chain and identify where triage, masking, rooming, testing, and contact tracing interrupt it.
---
Key Medications
Vitamin A: adults and children ≥12 months 200,000 IU PO daily for 2 days; 6–11 months 100,000 IU daily for 2 days; <6 months 50,000 IU daily for 2 days. Check public-health/institutional guidance, especially in pregnancy or liver disease.
Ceftriaxone: adults 1–2 g IV every 24 hours; children 50–75 mg/kg IV daily, maximum commonly 2 g.
Vancomycin: 15–20 mg/kg IV per dose; interval and monitoring vary—check pharmacy protocol.
Oseltamivir: adults 75 mg PO twice daily for 5 days; pediatric and renal dosing require a current reference.
MMR post-exposure prophylaxis: administer within 72 hours when indicated; product and dose depend on age and immunization status.
Measles immune globulin: exposure prophylaxis within 6 days for selected susceptible contacts; dose and route vary—public-health guidance is required.
Avoid aspirin in children with viral illness. Pediatric fluids and all antimicrobial doses must be weight-based.
High-Yield Pearls
Rash onset is not the first infectious day: measles spreads before the rash, so the exposure history begins with the prodrome.
Rubella’s mild maternal illness can conceal severe fetal consequences; every suspected rubella case requires pregnancy-focused contact assessment.
Fever that resolves before a child’s rash strongly favors roseola over measles.
The Mimics
Rubella — milder illness, posterior auricular/occipital nodes, and arthralgia; confusing it with measles misses major fetal risk and changes contact counseling.
Roseola — high fever resolves before the rash appears, usually in a well-appearing young child; treating the rash as measles delays correct exposure interpretation.
Parvovirus B19 — slapped-cheek appearance and lacy body rash, often without the 3 Cs; confusion threatens pregnant contacts and patients with hemolytic disease.
Drug eruption — temporal medication relationship and absent prodrome/Koplik spots; misclassification can trigger unnecessary outbreak investigation while missing a medication reaction.
Board Question
A patient with suspected measles presents to the ED. Which intervention should occur immediately, before confirmatory testing returns?
APlace the patient in a standard examination room with the door open
BPlace the patient in airborne isolation and notify public health
CAdminister MMR vaccine to the symptomatic patient and discharge
DWait for a positive IgM before restricting movement
Reveal answer
Correct: B
Place the patient in airborne isolation and notify public health. Measles is highly transmissible through airborne spread, and suspected cases require immediate isolation and public-health coordination. Testing should be obtained, but it must not delay infection-control measures.
5 of 6 · Procedure Corner
How to Buffer Lidocaine with Sodium Bicarbonate
Reduce the burning associated with infiltration of acidic lidocaine solutions, especially for large-volume infiltration, facial wounds, or anxious...
Also known aslidocaine buffering · lidocaine with bicarb
0:00 / –:––AI‑generated audio
Indications
Reduce the burning associated with infiltration of acidic lidocaine solutions, especially for large-volume infiltration, facial wounds, or anxious patients.
Consider when performing local anesthesia in children or in highly sensitive areas.
Buffering does not increase the maximum safe dose or eliminate the need for adequate analgesia and preparation.
Contraindications
Known allergy or contraindication to lidocaine or the planned local anesthetic.
Do not add bicarbonate to a solution that is already alkalinized unless compatibility and concentration are known.
Avoid routine buffering of bupivacaine or other long-acting amide anesthetics because alkalinization can cause precipitation; use the product-specific guidance.
Do not use a visibly cloudy, precipitated, contaminated, mislabeled, or expired preparation.
Equipment & Prep
Lidocaine at the intended concentration, with or without epinephrine as clinically appropriate.
Sterile syringe and needle or transfer device; alcohol or antiseptic wipe.
New administration syringe after mixing, if needed.
Calculate the total lidocaine dose, including any other local anesthetic already given. Follow a current dosing reference, particularly in infants, young children, pregnancy, hepatic disease, or low body weight.
A common starting mixture is 1 mL of 8.4% sodium bicarbonate added to 9–10 mL of lidocaine, approximately 1:10 by volume. Use less bicarbonate if directed by the product or local protocol.
Steps
Confirm the patient, procedure, allergies, anesthetic concentration, maximum planned dose, and presence or absence of epinephrine.
Draw the required volume of lidocaine into a sterile syringe or sterile mixing container.
Draw sodium bicarbonate separately. Do not inject bicarbonate into a multidose vial unless the vial is specifically intended for that use.
Add approximately 1 mL of 8.4% bicarbonate per 9–10 mL of lidocaine. Mix gently; do not vigorously shake.
Inspect immediately for cloudiness, crystals, or precipitate. If present, discard and prepare a fresh mixture.
Label the syringe with drug, final concentration if altered, additives, time prepared, and initials.
Use promptly for local infiltration with standard aspiration and incremental injection technique.
Confirmation & Success Criteria
The solution remains clear and free of precipitate.
The intended total anesthetic dose and volume are documented before injection.
The patient reports less burning or tolerates infiltration better than with unbuffered solution; analgesic efficacy remains adequate.
No evidence of intravascular injection or local anesthetic systemic toxicity occurs.
Complications & Rescue
Precipitation or loss of potency: Stop using the mixture; discard it and prepare a fresh compatible solution.
Pain despite buffering: Slow the injection, use a small needle, warm the solution toward room temperature, infiltrate through already anesthetized skin when possible, and reassess technique and diagnosis.
Local anesthetic systemic toxicity: Stop injection, call for help, support airway and circulation, treat seizures with a benzodiazepine, and follow the institutional lipid-emulsion protocol.
Intravascular injection: Stop immediately; monitor for neurologic or cardiovascular symptoms and manage as local anesthetic systemic toxicity.
Tissue irritation or ischemia: Reassess concentration, volume, epinephrine use, and injection location; obtain specialty input for persistent blanching, severe pain, or tissue injury.
Medication error: Stop administration, identify the total dose and concentration, monitor the patient, and contact pharmacy or poison control as appropriate.
Aftercare & Documentation
Record anesthetic name, concentration, epinephrine status, bicarbonate concentration and volume, total volume, total dose, route, site, time, and patient response.
Document the maximum-dose calculation and all other local anesthetics administered.
Discard unused mixed solution according to institutional policy; do not store or reuse it unless compatibility, sterility, and beyond-use requirements are explicitly established.
Reassess sensory and motor function, wound pain, and signs of local anesthetic toxicity during and after the procedure.
6 of 6 · Procedure Corner
Nasal Foreign Body Extraction Using Balloon Catheter
A smooth, nonpenetrating nasal foreign body that is beyond the anterior nares and can be bypassed with a small balloon catheter.A patient who can remain...
0:00 / –:––AI‑generated audio
Indications
A smooth, nonpenetrating nasal foreign body that is beyond the anterior nares and can be bypassed with a small balloon catheter.
A patient who can remain reasonably still for brief visualization and extraction.
Objects that are difficult to grasp but can be displaced anteriorly by traction on a balloon positioned behind them.
Contraindications
Suspected button battery, paired magnets, sharp or penetrating object, significant epistaxis, septal injury, or tissue necrosis: obtain urgent ENT involvement and use a battery- or object-specific pathway.
Object that cannot be visualized or safely bypassed.
Gloves, mask, eye protection, suction, gauze, emesis basin, and monitoring as clinically indicated.
Bright light, nasal speculum or otoscope, and appropriate nasal suction.
Small balloon catheter, such as a 5–8 Fr Fogarty catheter or another device designed for nasal foreign-body removal; follow the device’s recommended balloon volume.
Water-soluble lubricant, topical vasoconstrictor when appropriate, and topical anesthetic if needed and safe for the child.
Positive-pressure or oral suction backup, and ENT consultation access.
Explain that the catheter will pass beyond the object and that traction may briefly feel uncomfortable. Position the child securely, with an assistant stabilizing the head.
Steps
Assess airway, breathing, oxygenation, bleeding, object type, duration, and the status of the opposite nostril. Identify and urgently escalate suspected batteries, magnets, sharp objects, or penetrating injury.
Seat the patient upright when feasible. Inspect the nostril with direct lighting and suction away secretions or blood. Apply topical vasoconstrictor and anesthetic according to local protocol if mucosal swelling or discomfort limits visualization.
Lubricate the deflated catheter and gently advance it along the nasal floor, under direct visualization, until the balloon is clearly beyond the foreign body. Do not force resistance.
Inflate the balloon with the smallest volume that provides a secure purchase, using the manufacturer’s guidance; commonly only a fraction of a milliliter is needed in a child. Do not overinflate.
Apply slow, steady anterior traction while maintaining the catheter’s alignment with the nasal floor. Withdraw the catheter and object together.
If unsuccessful after a careful attempt, stop, reassess visualization and object position, and obtain ENT assistance or use another planned technique rather than repeated blind attempts.
Reinspect both nasal passages and the posterior oropharynx for retained material, bleeding, or injury. Confirm the object is intact.
Confirmation & Success Criteria
The foreign body is removed intact without posterior displacement or aspiration.
Direct reinspection shows no retained material, significant mucosal laceration, septal hematoma, or ongoing uncontrolled epistaxis.
The patient has a patent airway, stable oxygenation, and improving comfort.
If the object is a battery or magnet, verify urgent specialty evaluation even if it appears to have been removed, because mucosal injury or retained fragments may be present.
Complications & Rescue
Bleeding: Stop instrumentation, apply gentle pressure with gauze or a topical vasoconstrictor when appropriate, suction blood, and escalate for persistent or brisk hemorrhage.
Posterior displacement or aspiration: Stop attempts, assess airway immediately, provide suction and oxygen, and follow the foreign-body airway protocol.
Mucosal trauma or septal injury: Stop manipulation, control bleeding, and evaluate for septal hematoma or perforation; obtain ENT consultation for significant injury.
Balloon rupture or retained catheter fragment: Inspect the removed device and nasal cavity; retrieve any visible fragment and consult ENT if uncertain.
Pain, panic, or movement: Stop, reassure, optimize positioning and topical anesthesia, and consider procedural sedation only with appropriate monitoring, personnel, and rescue capability.
Failed extraction: Avoid repeated attempts; consult ENT, particularly for posterior, impacted, sharp, battery, magnetic, or chronically retained objects.
Unrecognized battery or magnet: Treat as an urgent condition, minimize delay, and involve ENT or poison control according to local protocol.
Aftercare & Documentation
Document the object’s type, location, nostril, condition, number and type of attempts, catheter size, balloon volume, medications, and whether the object was removed intact.
Record pre- and post-procedure airway status, bleeding, mucosal findings, patient tolerance, and complications.
Give return precautions for recurrent bleeding, fever, worsening pain, foul unilateral drainage, obstruction, respiratory symptoms, or concern for retained fragments.
For uncomplicated removal, advise against inserting objects into the nose and avoid forceful nose blowing until discomfort and bleeding have resolved.
Arrange ENT follow-up when there is significant trauma, suspected retained material, battery or magnet exposure, persistent symptoms, or an unsuccessful attempt.
Yesterday’s Differential
The daily puzzle — from editions past
A quick test of recall from prior editions. Commit to an answer before you check.
From yesterday's edition
An 82-year-old man with a dual-chamber device comes in for a fall. Vitals are stable. What’s the diagnosis, and the first move?
Check your answer
Normal Pacemaker Function. Confirm capture and appropriate inhibition before calling a device problem: verify each spike is followed by a P wave or QRS, recognize fusion/capture beats and appropriate discordance as normal, and reserve interrogation and electrophysiology involvement for genuine failure to capture, sense, or pace.
From the August 23 edition
Today, three days ago: Furosemide. What’s the adult ED dose, and the contraindication you’d most regret missing?
Check your answer
Diuretic-naive: 20–40 mg IV. Chronic users: IV dose often equals or exceeds total daily home oral dose, adjusted to severity and renal function. Anuria unresponsive to test dose, sulfonamide severe reaction caution, profound hypovolemia/electrolyte depletion.
From the August 16 edition
A 42-year-old man develops unilateral neck pain and transient right-eye blindness after chiropractic neck manipulation. CT head is normal; CTA shows an extracranial internal carotid artery dissection. He has no current deficit. Which is the best next step?
AImmediate systemic thrombolysis
BAspirin and admission for neurologic observation
CEmergent carotid endarterectomy in all cases
DTherapeutic lumbar puncture
Reveal answer
Correct · B
Stable patients without persistent disabling deficits generally receive antithrombotic therapy, commonly antiplatelet therapy, after intracranial hemorrhage is excluded. Thrombolysis is for eligible acute disabling ischemic stroke, not an asymptomatic or resolved dissection by itself.
Journal Watch
From the FOAMed wire
Notable posts and reviews from the last week, ranked by relevance to today’s lead and source trust.
Discover how restrictive fluids and early vasopressors impact 90-day septic shock outcomes. The post Fluids or Pressors in Early Septic Shock? appeared first on ACEP Now .
In this episode, Sam Ashoo, MD and Dr. Syeda Maria Muzammil, MD discuss the August 2026 Emergency Medicine Practice article, Emergency Department Management of Postthrombolysis Intracranial Hemorrhage. 0:25 – Intro & sponsor message 1:18 – Guest introduction: Dr. Maria Muzammil 2:24 – Timeframe for post-thrombolysis hemorrhage & ED/ICU boarding...
Jenny Beck-Esmay and Matthew DeLaney step in for the main show this month, covering 20 papers in depth. Aaron Skolnik joins Jess Monas for the Ultra Summary. Ken and Swami look at an article by Chris Carpenter et al....
Annals Journal Watch
From the specialty flagship
One recent paper from Annals of Emergency Medicine worth knowing on shift, chosen for practice impact — independent of today’s topics.
American College of Emergency Physicians Clinical Policies Subcommittee (Writing Committee) on Direct Oral Anticoagulants, Tomaszewski CA, Gottlieb M, et al. · PMID 42618190
An ACEP clinical policy synthesizes the evidence around a critical DOAC-related decision in adult ED patients, a common high-risk scenario with major implications for bleeding and thrombotic outcomes. Residents should know how its recommendations compare with their local protocols.
Bottom line → Review this policy and confirm that your ED’s DOAC evaluation and management pathway, available assays, reversal agents, and consultation triggers are aligned with its recommendations.
Critical Care Corner
Matched to today’s topics
A critical-care reference from LITFL’s Critical Care Compendium, tied to today’s differential.
Varicella’s transmission routes, complications, and isolation implications sharpen the approach to a child with chickenpox—especially when pulmonary or neurologic involvement signals severe disease.
Varicella Zoster VZV = an alpha herpes virus; 90% of adults have evidence of infection; spread via droplet excreted from the throat of patients with chicken pox OR via contact with vesicle fluid in chicken pox or shingles.
Pharmacology Corner
Two drugs for the shift
One antimicrobial and one other ED workhorse — selected daily, with sources and last-reviewed dates so every dose is cross-checkable.
Antimicrobial of the Day
Vancomycin
Glycopeptide
Indication
Empiric MRSA coverage; serious gram-positive infections including bacteremia, endocarditis, pneumonia, complicated SSTI, and meningitis.
What’s your dose? — reveal dosing & cautions
ED Dose
Loading 25–30 mg/kg IV (actual body weight; max 3 g) for serious infections; maintenance 15–20 mg/kg IV q8–12h.
Renal Adjustment
Reduce frequency in CrCl < 50 mL/min; AUC/trough-guided after loading. Hemodialysis: 15–20 mg/kg load, redose by level.
Contraindications
Known hypersensitivity. Caution with concurrent nephrotoxins.
Interactions
Piperacillin-tazobactam and aminoglycosides (additive nephrotoxicity); non-depolarizing neuromuscular blockers (potentiation).
Monitoring
AUC24 400–600 mg·h/L preferred (or trough 15–20 mg/L) for serious MRSA. Renal function daily. Infuse ≥ 60 min per gram to prevent vancomycin infusion reaction.
ED Pearl
The ED loading dose is weight-based, not capped at 1 g — undertreating sepsis with a reflex 1 g dose is the classic miss.
Procedural sedation, RSI induction (especially in shock), analgesia (sub-dissociative dosing), agitated delirium / excited delirium, refractory status asthmaticus.
What’s your dose? — reveal dosing & cautions
ED Dose
RSI induction: 1.5–2 mg/kg IV. Procedural sedation: 1–2 mg/kg IV or 4–5 mg/kg IM. Sub-dissociative analgesia: 0.1–0.3 mg/kg IV (or 0.5 mg/kg IN). Excited delirium: 4–5 mg/kg IM.
Renal Adjustment
No specific renal adjustment.
Contraindications
Schizophrenia (relative — risk of psychotic decompensation); known hypersensitivity. Historic contraindication of elevated ICP is largely refuted; use with hemodynamic awareness.
Continuous SpO2 + ETCO2 during dissociative dosing; cardiac monitor; have airway equipment at bedside (laryngospasm is rare but possible).
ED Pearl
Dose-dependent personality: at 0.1–0.3 mg/kg it's an opioid-sparing analgesic with minimal dissociation; at ≥1 mg/kg it's a full dissociative — dose error here is the main source of bad ED experiences with ketamine.
For educational use only. Verify dosing against the FDA label and your institution’s pharmacy resources before administering.
ECG of the Day
Rhythm
Atrioventricular Re-entry Tachycardia (AVRT)
A regular SVT with retrograde P waves at a long RP interval — or a regular broad-complex tachycardia in a young patient — should raise an accessory pathway.
The Tracing
A 24-year-old man presents with the abrupt onset of palpitations and lightheadedness that began while lifting weights. Blood pressure is 108/70, he is alert. The monitor shows a regular narrow-complex tachycardia at 200 bpm. Studying V1, you find a small notch at the beginning of each T wave — a retrograde P wave sitting well after the QRS, giving a long RP interval. The QRS complexes are narrow, under 120 ms, and their amplitude varies slightly from beat to beat even though the baseline is steady. There are no clear delta waves during the tachycardia. He mentions he has been told before that his 'resting ECG looked unusual.'
Orthodromic form: narrow QRS (<120 ms) with retrograde P waves at a long RP interval (>70 ms), often a notch at the start of the T wave in V1 or lead III
Antidromic form: regular broad-complex tachycardia from anterograde conduction down the accessory pathway, easily mistaken for VT
QRS alternans (phasic beat-to-beat variation in QRS amplitude with a normal QRS amplitude)
Features of pre-excitation (delta wave) are lost during the tachycardia and may reappear in sinus rhythm
Rate-related ischemia is common
Pearls
The long RP interval is the fingerprint that separates orthodromic AVRT from typical AVNRT: in AVNRT the retrograde P is early (buried in the QRS or a pseudo-R' at its terminal portion), in AVRT it lands later after the QRS.
Reversion to sinus rhythm can be diagnostic — a WPW pattern appearing on the post-conversion ECG confirms the tachycardia was orthodromic AVRT; tall R waves in V1-3 point to a left-sided pathway.
In a young child, a regular broad-complex tachycardia is far more likely SVT with aberrancy than VT — over 95% of pediatric broad-complex tachycardias are SVT.
Pitfalls
Antidromic AVRT is a regular broad-complex tachycardia indistinguishable from VT at the bedside — if in doubt, treat as VT.
Giving an AV nodal blocker (adenosine, verapamil) in a pre-excited rhythm carries a small but real risk of inducing AF, which can then conduct rapidly down the accessory pathway and precipitate cardiac arrest.
Any AV nodal blocker can provoke AF even in orthodromic AVRT — if verapamil is used, observe for at least 4 hours.
At the Bedside
Cardiovert any unstable patient immediately. In stable orthodromic AVRT, slow AV nodal conduction stepwise — vagal maneuvers, then adenosine and/or verapamil. In stable antidromic AVRT, avoid AV nodal blockade and target the pathway with procainamide (first line), with cardioversion held in reserve.
For educational use only. Verify ECG interpretation against the LITFL entry and your institution’s practice before clinical decision-making.
Case of the Day
From the lead · Minor Procedures and Sedation/Analgesia
Self-Examination
Test Your Understanding
A 6-year-old requires painful fracture reduction. He is alert, hemodynamically stable, and has no significant comorbidities. Which medication best provides dissociative analgesia and immobility while generally preserving spontaneous respiration?
AMidazolam
BKetamine
CFentanyl
DFlumazenil
Reveal answer
Correct answer · B
Ketamine. Ketamine produces dissociative anesthesia with analgesia and usually preserves spontaneous ventilation and airway reflexes, though monitoring and rescue capability remain mandatory. Midazolam and fentanyl do not reliably provide adequate procedural immobility alone and can depress ventilation.
Study Pace4 topics today; Issue 43 of 94 — Pediatrics (Weeks 23 A-23 B)Deadline · June 1, 2026